Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Schwartz Daniel Mark — RxSight, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / Schwartz Daniel Mark

Schwartz Daniel Mark

Director at RxSight, Inc. · on record since Jul 29, 2021

Insider trading activity of Schwartz Daniel Mark

Transactions on record: 2; since Aug 5, 2021

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Aug 5, 2021

Figures computed from official regulatory filings — methodology.

Companies where Schwartz Daniel Mark has traded

RxSight, Inc.2 tx · Aug 5, 2021

Track record of Schwartz Daniel Mark

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Schwartz Daniel Mark

Co-insiders of Schwartz Daniel Mark

Andrews JulieRxSight, Inc.
COHEN RAYMOND WRxSight, Inc.
Corley Jesse AndersonRxSight, Inc.
Cox ChristopherRxSight, Inc.
Fountain TamaraRxSight, Inc.
Gaines ScottRxSight, Inc.
Goldshleger IlyaRxSight, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Kolchinsky PeterRxSight, Inc.

Kurtz Ronald M MDRxSight, Inc.

LINK WILLIAM J PHDRxSight, Inc.

Maniar ShwetaRxSight, Inc.

PALMISANO ROBERT JRxSight, Inc.

RA Capital Biotech Fund LPRxSight, Inc.

RA CAPITAL MANAGEMENT, LLCRxSight, Inc.

Robertson Bruce CRxSight, Inc.

RxSight I, LLCRxSight, Inc.

Shah Rajeev M.RxSight, Inc.

Tammenoms Bakker JulietRxSight, Inc.

Thunen Shelley BRxSight, Inc.

Warner Robert KeithRxSight, Inc.

Weinberg EricRxSight, Inc.

Wilterding MarkRxSight, Inc.

Wolfen Richard M.RxSight, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
RxSight, Inc.	Aug 5, 2021	OtherD	-3,872	0.00 USD	$0	SEC
RxSight, Inc.	Aug 5, 2021	Other	3,969	0.00 USD	$0	SEC